NCT05936346

Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient

Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: IBSA Farmaceutici Italia Srl · Industry
• Sex: All
• Age: 55 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.

Detailed description

The aim of the study is to assess the safety and tolerability of the oral administration of Salvia haenkei in a healthy population. Furthermore, Salvia haenkei has been identified as a potential anti-senescence agent and may counteract aging and aging-associated disorders. In this scenario, the current study aims also at exploring the effects of this supplementation on muscular and other organ functions (kidney, liver, heart, etc.) and on systemic inflammation and metabolism.

Conditions

• Aging

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Salvia haenkei 175mg	The product appears as a soft gel containing the dry extract of Salvia haenkei
DIETARY_SUPPLEMENT	Salvia haenkei 350mg	The product appears as a soft gel containing the dry extract of Salvia haenkei

Timeline

• Start date: 2023-07-17
• Primary completion: 2025-04-30
• Completion: 2025-04-30
• First posted: 2023-07-07
• Last updated: 2025-01-23

Locations

1 site across 1 country: Switzerland